Browsing Tag
NASDAQ
289 posts
Broadcom stock gains after Q3 earnings beat, AI revenue hits $5.2bn milestone
Broadcom stock rose after Q3 FY2025 earnings beat estimates. Find out what’s driving AVGO’s AI revenue and semiconductor momentum this quarter.
Resolution Minerals (ASX: RML) weighs Snow Lake exclusivity as Horse Heaven drilling begins
Resolution Minerals balances Snow Lake exclusivity with Horse Heaven drilling. Find out how both moves could reshape U.S. critical minerals supply.
Vyome completes merger with ReShape Lifesciences, to debut on Nasdaq as Vyome Holdings (HIND) on August 15
Vyome merges with ReShape Lifesciences, will trade on Nasdaq as Vyome Holdings (HIND) from August 15, focusing on immuno-inflammatory and rare diseases.
Why Mogo just sold half its WonderFi stake—and what it means for investors
Mogo has reduced its WonderFi stake to 6.34%, triggering an early warning filing. Find out what this move signals for future investor strategy.
Can defense AI startups scale securely using NVIDIA’s enterprise-grade tech in 2025?
Find out how NVIDIA is powering secure, scalable defense AI startups using NeMo Guardrails, Modulus, and sovereign GPU infrastructure in 2025 and beyond.
NVIDIA vs AMD: Who’s winning the AI chip war in 2025? A full-stack performance and market share comparison
Explore how NVIDIA and AMD compare in the 2025 AI chip race. From performance benchmarks to cloud deployments, here’s who’s leading the infrastructure war.
Jensen Huang leadership profile: How the NVIDIA CEO built the backbone of global AI infrastructure
Explore how NVIDIA CEO Jensen Huang shaped the AI economy with long-cycle vision, product depth, and global partnerships. Read the 2025 leadership profile.
PDD Holdings (PDD) stock watch: What triggered the 13% drop and is it a buying opportunity?
PDD stock fell 13.6% on May 27 amid Chinese tech volatility. Find out what triggered the drop, how institutions reacted, and whether Temu’s growth can revive sentiment.
Apellis Pharmaceuticals gains 6.66% as investors bet on Q2 trial update and long-term pipeline potential
Apellis Pharmaceuticals stock jumped 6.66% as investors bet on key trial updates and undervalued biotech potential. Will FDA decisions drive more upside?
Coinbase data breach 2025: Insider threat exposes government IDs and user data, triggers $400m fallout
Coinbase insider breach exposes IDs and user data; investors assess $400M fallout, security reforms, and S&P 500 debut. Read full breakdown.